JBC, Vol. 250, Issue 20, 8016-8022, Oct, 1975

Activation of guanylate cyclase from rat liver and other tissues by sodium azide

H. Kimura, C. K. Mittal and F. Murad

Sodium azide, hydroxylamine, and phenylhydrazine at concentrations of 1 mM increased the activity of soluble guanylate cyclase from rat liver 2- to 20-fold. The increased accumulation of guanosine 3':5'-monophosphate in reaction mixtures with sodium azide was not due to altered levels of substrate, GTP, or altered hydrolysis of guanosine 3':5'-monophosphate by cyclic nucleotide phosphodiesterase. The activation of guanylate cyclase was dependent upon NaN3 concentration and temperature; preincubation prevented the time lag of activation observed during incubation. The concentration of NaN3 that resulted in half-maximal activation was 0.04 mM. Sodium azide increased the apparent Km for GTP from 35 to 113 muM. With NaN3 activation the enzyme was less dependent upon the concentration of free Mn2+. Activation of enzyme by NaN3 was irreversible with dilution or dialysis of reaction mixtures. The slopes of Arrhenius plots were altered with sodium azide-activated enzyme, while gel filtration of the enzyme on Sepharose 4B was unaltered by NaN3 treatment. Triton X-100 increased the activity of the enzyme, and in the presence of Triton X-100 the activation by NaN3 was not observed. Trypsin treatment decreased both basal guanylate cyclase activity and the responsiveness to NaN3. Phospholipase A, phospholipase C, and neuraminidase increased basal activity but had little effect on the responsiveness to NaN3. Both soluble and particulate guanylate cyclase from liver and kidney were stimulated with NaN3. The particulate enzyme from cerebral cortex and cerebellum was also activated with NaN3, whereas the soluble enzyme from these tissues was not. Little or no effect of NaN3 was observed with preparations from lung, heart, and several other tissues. The lack of an effect with NaN3 on soluble GUANYLATE Cyclase from heart was probably due to the presence of an inhibitor of NaN3 activation in heart preparations. The effect of NaN3 was decreased or absent when soluble guanylate cyclase from liver was purified or stored at -20degrees. The activation of guanylate cyclase by NaN3 is complex and may be the result of the nucleophilic agent acting on the enzyme directly or what may be more likely on some other factor in liver preparations.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. P. Rubin A Brief History of Great Discoveries in Pharmacology: In Celebration of the Centennial Anniversary of the Founding of the American Society of Pharmacology and Experimental Therapeutics Pharmacol. Rev., December 1, 2007; 59(4): 289 - 359. [Full Text] [PDF]

				F. Murad Nitric Oxide and Cyclic GMP in Cell Signaling and Drug Development N. Engl. J. Med., November 9, 2006; 355(19): 2003 - 2011. [Full Text] [PDF]

				F. Murad The Excitement and Rewards of Research With Our Discovery of Some of the Biological Effects of Nitric Oxide Circ. Res., March 7, 2003; 92(4): 339 - 341. [Full Text] [PDF]

				M. Straznicka, G. Gong, J. Tse, P. M. Scholz, and H. R. Weiss cGMP level that reduces cardiac myocyte O2 consumption is altered in renal hypertension Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1949 - H1955. [Abstract] [Full Text] [PDF]

				F. Murad What Are the Molecular Mechanisms for the Antiproliferative Effects of Nitric Oxide and cGMP in Vascular Smooth Muscle? Circulation, March 4, 1997; 95(5): 1101 - 1103. [Full Text]

				L. J. Olson, E. T. Knych Jr, T. C. Herzig, and J. G. Drewett Selective Guanylyl Cyclase Inhibitor Reverses Nitric Oxide-Induced Vasorelaxation Hypertension, January 1, 1997; 29(1): 254 - 261. [Abstract] [Full Text] [PDF]

				C. Paveto, C. Pereira, J. Espinosa, A. E. Montagna, M. Farber, Món. Esteva, M. M. Flawiá, and Héc. N. Torres The Nitric Oxide Transduction Pathway in Trypanosoma cruzi J. Biol. Chem., July 14, 1995; 270(28): 16576 - 16579. [Abstract] [Full Text] [PDF]

				H. Schmidt, T. Warner, K Ishii, H Sheng, and F Murad Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides Science, February 7, 1992; 255(5045): 721 - 723. [Abstract] [PDF]

				F. DeRubertis and P. Craven Calcium-independent modulation of cyclic GMP and activation of guanylate cyclase by nitrosamines Science, September 3, 1976; 193(4256): 897 - 899. [Abstract] [PDF]